These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35176948)

  • 1. Airway disease in hematologic malignancies.
    José RJ; Dickey BF; Sheshadri A
    Expert Rev Respir Med; 2022 Mar; 16(3):303-313. PubMed ID: 35176948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
    Weng G; Fan Z; Xue H; Huang F; Xu N; Jin H; Yu S; Ye Z; Fan J; Xuan L; Liu Q
    Front Immunol; 2022; 13():1036403. PubMed ID: 36389692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation.
    Scheidl S; Zinke-Cerwenka W; Flick H; Gaal S; Avian A; Greinix H; Olschewski H
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):129-136. PubMed ID: 30064013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchiolitis obliterans after stem cell transplantation for hematologic malignancies rescued by lung transplantation: A report of two cases.
    Suzuki J; Kasai H; Terada J; Shikano K; Sasaki A; Suzuki H; Nakajima T; Kouchi Y; Shiina M; Kobayashi T; Ohwada C; Ikeda JI; Yoshino I; Tatsumi K
    Respir Investig; 2021 Jul; 59(4):559-563. PubMed ID: 33883090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
    Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
    Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
    Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
    JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small airway diseases and immune deficiency].
    Burgel PR; Bergeron A; Knoop C; Dusser D
    Rev Mal Respir; 2016 Feb; 33(2):145-55. PubMed ID: 26854188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bergeron A; Cheng GS
    Clin Chest Med; 2017 Dec; 38(4):607-621. PubMed ID: 29128013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Galbán CJ; Boes JL; Bule M; Kitko CL; Couriel DR; Johnson TD; Lama V; Telenga ED; van den Berge M; Rehemtulla A; Kazerooni EA; Ponkowski MJ; Ross BD; Yanik GA
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1592-8. PubMed ID: 24954547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
    Chien JW; Duncan S; Williams KM; Pavletic SZ
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Cheng GS; Selwa KE; Hatt C; Ram S; Fortuna AB; Guerriero M; Himelhoch B; McAree D; Hoffman TC; Brisson J; Nazareno R; Bloye K; Johnson TD; Remberger M; Mattsson J; Vummidi D; Kazerooni EE; Lama VN; Galban S; Boeckh M; Yanik GA; Galban CJ
    Am J Transplant; 2020 Aug; 20(8):2198-2205. PubMed ID: 32034974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation.
    Kuroi T; Fujii N; Ichimura K; Seike K; Yamamoto A; Kambara Y; Sugimoto S; Otani S; Saeki K; Fujiwara H; Nishiomori H; Oto T; Maeda Y
    Int J Hematol; 2021 Dec; 114(6):701-708. PubMed ID: 34494183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies.
    Nathan S; Ustun C
    Infect Dis Clin North Am; 2019 Jun; 33(2):331-359. PubMed ID: 30940464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
    Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
    Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
    Cheng GS; Bondeelle L; Gooley T; He Q; Jamani K; Krakow EF; Flowers MED; de Latour RP; Michonneau D; Socié G; Chien JW; Chevret S; Bergeron A
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):392-400. PubMed ID: 31682980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.